38074--5/30/2007--FOREST_LABORATORIES

related topics

{product, candidate, development}

{product, liability, claim}

{customer, product, revenue}

{property, intellectual, protect}

{tax, income, asset}

{financial, litigation, operation}

{acquisition, growth, future}

{regulation, government, change}

We are Substantially Dependent on Sales of Our Two Principal Products. Pharmaceutical Research is Expensive and Uncertain. Regulatory Compliance Issues Could Materially Affect Our Operations. Our Business Depends on Intellectual Property Protection. Our Business Model Currently Depends on the Successful In-Licensing or Acquisition of New Product Opportunities. Pharmaceutical Cost-Containment Initiatives May Negatively Affect Our Net Income. We face Substantial Competition from Other Pharmaceutical Manufacturers and Generic Product Distributors. Our Business, and in Particular the Treatment of CNS Disorders, Presents Risk of Product Liability Claims. The Effective Rate of Taxation upon Our Results of Operations is Dependent on Multi-National Tax Considerations. Our Business Could be Negatively Affected By the Performance of Our Collaboration Partners. Many of our Principal Products and Active Pharmaceutical Ingredients are Only Available From a Single Manufacturing Source

Full 10-K form ▸

38074--5/30/2007--FOREST_LABORATORIES_INC